Status:
UNKNOWN
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
Lead Sponsor:
Liaoyang Central Hospital
Conditions:
Apnea
Snoring
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS \& SS,to reduce pharyngeal compliance.
Detailed Description
Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection.The injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal subm...
Eligibility Criteria
Inclusion
- OSAS \& SS which palatopharyngeal collapse.
Exclusion
- obstructive sleep apnea syndrome (osas) \& snoring subjects (ss),which anatomic narrow result in.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00399451
Start Date
December 1 2006
End Date
June 1 2009
Last Update
November 22 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.